| Literature DB >> 20382242 |
Dahlene Fusco1, Xinyan Liu, Caroline Savage, Ying Taur, Weilie Xiao, Edward Kennelly, Jianda Yuan, Barrie Cassileth, Mirella Salvatore, Genovefa A Papanicolaou.
Abstract
Influenza infection is a major clinical problem and Echinacea purpurea, a widely consumed botanical product, is purported to alter the course of respiratory infections including influenza. Mice infected with WSN influenza A and treated with E. purpurea polysaccharide extract had less weight loss than untreated mice but similar pulmonary viral titers. Echinacea-treated mice had lower systemic and pulmonary KC and IL-10 levels and lower systemic IFN-gamma levels following influenza infection. These suggest that E. purpurea alters the clinical course of influenza infection in mice through modulation of cytokines and not direct antiviral activity. Copyright 2010. Published by Elsevier Ltd.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20382242 PMCID: PMC3016056 DOI: 10.1016/j.vaccine.2010.03.047
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641